U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 10:12:43 GMT 2023
Edited
by admin
on Sat Dec 16 10:12:43 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
T13V17U431
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VADASTUXIMAB TALIRINE
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
SGN-CD33A
Code English
SGNCD33A
Code English
vadastuximab talirine [INN]
Common Name English
Vadastuximab talirine [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD33 (SIALIC ACID BINDING LG-LIKE LECTIN 3, SIGLEC3, SIGLEC-3, GP67, P67)), CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PDB) DIMER SGD-1882 GAMMA1 HEAVY CHAIN (1-447) (MUS MUSCULUS VH
Systematic Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 3) (HUMAN-MUS MUSCULUS MONOCLONAL H2H12EC HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL H2H12EC LIGHT CHAIN, DIMER, BIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-
Systematic Name English
VADASTUXIMAB TALIRINE [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 494515
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
NCI_THESAURUS C1512
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
NCI_THESAURUS C129823
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
Code System Code Type Description
USAN
CD-154
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
DRUG BANK
DB11884
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
WIKIPEDIA
Vadastuximab talirine
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
CAS
1436390-64-5
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
NCI_THESAURUS
C111039
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
INN
9983
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
FDA UNII
T13V17U431
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
EVMPD
SUB182510
Created by admin on Sat Dec 16 10:12:43 GMT 2023 , Edited by admin on Sat Dec 16 10:12:43 GMT 2023
PRIMARY
From To
1_22 1_96
1_144 1_200
1_261 1_321
1_367 1_425
2_22 2_96
2_144 2_200
2_261 2_321
2_367 2_425
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_220 3_214
2_220 4_214
1_226 2_226
1_229 2_229
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_297
N 2_297
Related Record Type Details
MYELOID CELL SURFACE ANTIGEN CD33
TARGET -> INHIBITOR
Related Record Type Details
VADASTUXIMAB TALIRINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966